跳至主要内容
临床试验/NCT01951079
NCT01951079Unknown3 期

The Safety and Outcome of Intra-amniotic DIGOXIN Injection for Feticide Prior to Second Trimester Abortion

Meir Medical Center2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2013年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
100
试验地点
2
主要终点
Efficiency of intra-amniotic Digoxin injection for second trimester feticide

研究概览

简要总结

In second trimester abortion above 22 weeks the investigators usually inject intra-cardiac Kcl for feticide. Digoxin intra-amniotic injection has been described in the literature in doses of 1-1.5 mg. with a success rate of about 80%, and up to 24 weeks. Our aim in this study is to investigate the safety and success rate of 1.5-2 mg. digoxin, intra-amniotic up to 30 weeks pregnancy .

详细描述

  • The digoxin will be injected intra-amniotic with U.S guided, trying to avoid any placental passage or intravascular injection /
  • Any patient will have prior to the procedure a full examination including E.C.G and cardiac clearance.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • healthy women with no medical, cardiac, hypertension, liver or renal problems - pregnant in their 20-30 week gestation,
  • that need to have abortion due to fetal anomalies or any other reason
  • need to have feticide prior to the procedure

排除标准

  • any patient with medical problem that may be a contra-indication to Digoxin
  • cardiac problems,
  • prior cardiac surgery,
  • liver or kidney disease,
  • hyper tension etc.

研究组 & 干预措施

second trimester abortion , feticide

Experimental

all patients admitting to second trimester abortion above 22 weeks will be injected intra-amniotic DIGOXIN for feticide .

干预措施: Intra-amniotic injection of DIGOXIN (Drug)

结局指标

主要结局

Efficiency of intra-amniotic Digoxin injection for second trimester feticide

时间窗: a year

To measure the Success rate of intra-amniotic Digoxin injection for feticide prior to second trimester abortion

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验